Healthcare -
Biotechnology - NASDAQ - CN
$ 28.61
-5.07 %
$ 314 M
Market Cap
-11.3
P/E
INCOME STATEMENT
EFFICIENCY
Earnings Waterfall
Zai Lab Limited
| Revenue | 399 M |
| Cost Of Revenue | 148 M |
| Gross Profit | 251 M |
| Operating Expenses | 533 M |
| Operating Income | -282 M |
| Other Expenses | -25 M |
| Net Income | -257 M |
Income Statement
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||
| Revenue | 399.0 | 266.7 | 215.0 | 144.3 | 49.0 | 13.0 | 0.1 | 0 | 0 | 0 |
| GROSS PROFIT | ||||||||||
| Cost Of Revenue | 147.9 | 95.8 | 74.0 | 52.2 | 16.7 | 3.7 | 43.6 K | 0 | 0 | 0 |
| Gross Profit | 251.1 | 170.9 | 141.0 | 92.1 | 32.2 | 9.2 | 85.9 K | 0 | 0 | 0 |
| OPERATING INCOME | ||||||||||
| Operating Expenses | 533.2 | 537.5 | 545.4 | 792.1 | 334.0 | 212.4 | 141.9 | 51.4 | 38.5 | 16.3 |
| Selling, General and Administrative Expenses | 298.7 | 281.6 | 259.0 | 218.8 | 111.3 | 70.2 | 21.6 | 12.0 | 6.4 | 2.8 |
| Research and Development Expenses | 234.5 | 265.9 | 286.4 | 573.3 | 222.7 | 142.2 | 120.3 | 39.3 | 32.1 | 13.6 |
| Operating Income | (282.1) | (366.6) | (404.4) | (700.1) | (301.8) | (203.2) | (141.8) | (51.4) | (38.5) | (16.3) |
| PRE-TAX INCOME | ||||||||||
| Interest Income Expense | 2.3 | 0 | 14.6 | 0 | 0.2 | 0.3 | 39.7 K | 0 | 0 | 0 |
| Total Other Income | 25.0 | 32.0 | (38.7) | (3.4) | 34.0 | 8.9 | 3.3 | 1.0 | 1.0 | (1.7) |
| Pre-Tax Income | (257.1) | (334.6) | (443.1) | (703.4) | (267.8) | (194.3) | (138.5) | (50.1) | (37.5) | (18.0) |
| NET INCOME | ||||||||||
| Tax Provision | 0 | 0 | 38.9 | (11.0) | 30.4 | (11.0) | 3.3 | (0.5) | 1.5 | 2.0 |
| Net Income | (257.1) | (334.6) | (482.0) | (692.4) | (298.2) | (183.4) | (139.1) | (50.4) | (37.5) | (18.0) |
| EPS | 26 | 34.6 | 46.3 | 75.8 | 34.6 | 30.3 | 26.4 | 23.2 | 39.7 | 20.7 |